Clinical Trials Browser

Phase 1 × 3rd Line GIST × Alpelisib × Clear all

NCT01735968 2020-12-21

A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients

Phase 1 Completed

3rd Line GIST